BioPharmSignal logoBioPharmSignal

Biotech News

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

Curis Inc (CRIS)Curis Inc2026-06-25 13:46 ESTFinancing

CRIS (CRIS) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is cris.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

CRISCuris Inc2026-06-25 13:46 EST

Curis Provides First Quarter 2026 Business Update

CRISCuris Inc2026-06-25 13:46 EST

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

CRISCuris Inc2026-06-25 13:46 EST

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

CRISCuris Inc2026-06-25 13:46 EST

Curis Provides Fourth Quarter 2025 Business Update

CRISCuris2026-06-25 13:46 EST

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

NRSNNeuroSense Therapeutics2026-06-25 13:46 EST

NeuroSense Reports Positive Biomarker Findings from Phase 2 RoAD Proof-of-Concept Study of PrimeC in Alzheimer's Disease

JAGXJaguar Health2026-06-25 13:46 EST

Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend

MKTMaia Biotechnology2026-06-25 13:46 EST

MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer

CADLCandel Therapeutics2026-06-25 13:46 EST

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

ICCMIceCure Medical2026-06-25 13:46 EST

IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement

View all latest news

Curis Inc

Curis is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

CRISCuris Inc2026-06-26 09:43 EST

Curis Provides First Quarter 2026 Business Update

CRISCuris Inc2026-06-26 09:43 EST

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

CRISCuris Inc2026-06-26 09:43 EST

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

CRISCuris Inc2026-06-26 09:43 EST

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

CRISCuris Inc2026-06-26 09:43 EST

Curis Provides Fourth Quarter 2025 Business Update

Stock data

Close
—
Market cap
—
Exchange
NASDAQ
Sector
Biotechnology
Location
United States